X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
female (38) 38
male (38) 38
middle aged (37) 37
aged (35) 35
diabetes (29) 29
type 2 diabetes (28) 28
endocrinology & metabolism (23) 23
atherosclerosis (19) 19
risk factors (18) 18
diabetes mellitus (16) 16
diabetes mellitus, type 2 - drug therapy (16) 16
adult (15) 15
diabetes mellitus, type 2 - complications (14) 14
clinical trials (13) 13
intima-media thickness (13) 13
hypoglycemic agents - therapeutic use (12) 12
risk (12) 12
care and treatment (11) 11
diabetes mellitus, type 2 - blood (11) 11
insulin (11) 11
original (11) 11
type 2 diabetes mellitus (11) 11
cardiovascular diseases (10) 10
glycemic control (10) 10
japan (10) 10
glucose (9) 9
hemoglobin (9) 9
original article (9) 9
peripheral vascular disease (9) 9
sitagliptin (9) 9
asian continental ancestry group (8) 8
coronary-heart-disease (8) 8
diabetes mellitus, type 2 - genetics (8) 8
hyperglycemia (8) 8
japan - epidemiology (8) 8
metformin (8) 8
patients (8) 8
safety (8) 8
arterial stiffness (7) 7
body mass index (7) 7
cardiovascular-disease (7) 7
clinical science and care (7) 7
endocrinology (7) 7
internal medicine (7) 7
mellitus (7) 7
myocardial-infarction (7) 7
polymorphism, genetic (7) 7
prospective studies (7) 7
analysis (6) 6
blood pressure (6) 6
cardiovascular disease (6) 6
carotid intima-media thickness (6) 6
diabetes mellitus, type 2 - epidemiology (6) 6
diabetes therapy (6) 6
diabetics (6) 6
dipeptidyl-peptidase iv inhibitors - therapeutic use (6) 6
drug therapy (6) 6
drug therapy, combination (6) 6
efficacy (6) 6
glycated hemoglobin a - metabolism (6) 6
glycosylated hemoglobin (6) 6
hypoglycemia (6) 6
japanese patients (6) 6
pharmacology & pharmacy (6) 6
physics (6) 6
research (6) 6
studies (6) 6
calculating (5) 5
cardiac & cardiovascular systems (5) 5
cardiovascular (5) 5
computing (5) 5
continuous glucose monitoring (5) 5
counting (5) 5
cross-sectional studies (5) 5
diabetes mellitus, type 2 - ethnology (5) 5
diabetes mellitus, type 2 - metabolism (5) 5
diabetes mellitus, type 2 - physiopathology (5) 5
disease progression (5) 5
double-blind method (5) 5
dpp-4 inhibitor (5) 5
electric digital data processing (5) 5
genetic aspects (5) 5
hypoglycemic agents - pharmacology (5) 5
imt (5) 5
medical research (5) 5
medicine & public health (5) 5
medicine, experimental (5) 5
polymorphism (5) 5
sglt2 inhibitor (5) 5
treatment outcome (5) 5
1-deoxynojirimycin - analogs & derivatives (4) 4
acarbose (4) 4
add-on therapy (4) 4
aged, 80 and over (4) 4
asian continental ancestry group - genetics (4) 4
blood glucose - metabolism (4) 4
cardiology (4) 4
cholesterol (4) 4
cohort studies (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLOS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173540
...Author(s): Takeshi Ogihara 1, Tomoya Mita 1,2,*, Yusuke Osonoi 1, Takeshi Osonoi 3, Miyoko Saito 3, Atsuko Tamasawa 3, Shiho Nakayama 1, Yuki Someya 1... 
DEPRESSION | SLEEP DURATION | GLYCEMIC CONTROL | RISK-FACTOR | ARTERIAL STIFFNESS | MULTIDISCIPLINARY SCIENCES | ADULTS | PHYSICAL-ACTIVITY | ALCOHOL-CONSUMPTION | CORONARY-HEART-DISEASE | MORNINGNESS-EVENINGNESS QUESTIONNAIRE | Japan - epidemiology | Life Style | Cardiovascular Diseases - metabolism | Cross-Sectional Studies | Humans | Middle Aged | Risk Factors | Male | Diabetes Mellitus, Type 2 - epidemiology | Cardiovascular Diseases - complications | Biomarkers | Adult | Diabetes Mellitus, Type 2 - etiology | Female | Surveys and Questionnaires | Aged | Kidney Diseases - complications | Kidney Diseases - metabolism | Type 2 diabetes | Cell metabolism | Research | Analysis | Life style | Physical activity | g-Glutamyltransferase | Clinical trials | Alcohol | Systematic review | Parameter identification | Quality | Questionnaires | Blood pressure | Lipoproteins (high density) | Diabetes mellitus (non-insulin dependent) | Heart diseases | Alanine | Factor analysis | Kidneys | Diabetes mellitus | Triglycerides | Regression analysis | Uric acid | Circadian rhythm | Cigarettes | Metabolism | Clustering | Cigarette smoking | Patients | Velocity | Cholesterol | Studies | Ankle | Hospitals | Sleep | Diet | Body mass | Alanine transaminase | Alcoholic beverages | Aspartate aminotransferase | Lifestyles | Diabetes | Wave velocity | Food consumption | Cardiovascular diseases | Endocrinology | Kidney transplantation
Journal Article
Journal of diabetes investigation, ISSN 2040-1116, 2018, Volume 9, Issue 5, pp. 1203 - 1211
Journal Article
Scientific reports, ISSN 2045-2322, 01/2020, Volume 10, Issue 1, pp. 1156 - 11
... factor of non-B non-c hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation Satoko Umetsu1,2, Hiroki Mizukami1*, takeshi Saito1,2... 
Cell proliferation | Liver cancer | Hepatitis | Medical prognosis | DNA methylation | Dihydropyrimidinase | Hepatocellular carcinoma | Diabetes | Hepatitis C | Diabetes mellitus (non-insulin dependent) | Hepatitis B | Tumors
Journal Article
Diabetes care, ISSN 1935-5548, 2016, Volume 39, Issue 1, pp. 139 - 148
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2018, Volume 20, Issue 2, pp. 378 - 388
Aims To assess the safety and efficacy of monotherapy with once‐weekly subcutaneous (s.c.) semaglutide vs sitagliptin in Japanese people with type 2 diabetes... 
GLP‐1 | sitagliptin | type 2 diabetes | GLP-1 | METFORMIN | ADD-ON | AMERICAN ASSOCIATION | HUMAN GLP-1 ANALOG | EXENATIDE | PHASE 3A | OPEN-LABEL | CLINICAL ENDOCRINOLOGISTS | LIRAGLUTIDE | ENDOCRINOLOGY & METABOLISM | ACUTE-PANCREATITIS | Glycated Hemoglobin A - analysis | Follow-Up Studies | Nausea - chemically induced | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Diarrhea - physiopathology | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glucagon-Like Peptides - administration & dosage | Humans | Nausea - physiopathology | Patient Dropouts | Weight Loss - drug effects | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Hypoglycemia - prevention & control | Diabetes Mellitus, Type 2 - ethnology | Glucagon-Like Peptide-1 Receptor - metabolism | Nausea - therapy | Injections, Subcutaneous | Hypoglycemia - chemically induced | Severity of Illness Index | Sitagliptin Phosphate - administration & dosage | Hyperglycemia - prevention & control | Drug Administration Schedule | Administration, Oral | Japan | Constipation - physiopathology | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Constipation - chemically induced | Glucagon-Like Peptides - adverse effects | Diabetes Mellitus, Type 2 - blood | Diarrhea - therapy | Constipation - therapy | Incretins - adverse effects | Sitagliptin Phosphate - therapeutic use | Glucagon-Like Peptides - therapeutic use | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Incretins - administration & dosage | Sitagliptin Phosphate - adverse effects | Type 2 diabetes | Glycosylated hemoglobin | Hypoglycemic agents | Glucagon | Diabetes mellitus | Body weight | Hemoglobin | Diabetes | Safety | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Original
Journal Article
Journal of Diabetes Investigation, ISSN 2040-1116, 07/2016, Volume 7, Issue 4, pp. 565 - 573
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e113468
Journal Article